As industry shifts to continuous biomanufacturing, engineers integrate process design, digital tools, automation, and ...
Chai Discovery is working with major drugmakers to use its latest antibody AI model to find new therapies. Now it’s in talks ...
Gilead Sciences is maintained at 'Hold' as the HIV franchise drives growth, but the oncology pipeline requires further ...
AsymBio’s Conjugation Toolbox supports customized process development across both random and site-specific conjugation ...
The nod for Zaynich—an antibiotic for treatment of complicated UTI—vindicates chairman and founder Habil Khorakiwala’s bet on ...
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...
More flexibility in early-phase development for cell therapies is needed, a panel of US Food and Drug Administration (FDA) ...
Purdue researchers developed a mass spectrometry system that accelerates chemical reactions without heat or catalysts, ...
Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as ...
Porton Advanced, a leading cell and gene therapy CDMO, recently announced its client Salvectors has received Investigational New Drug (IND) clearance for their proprietary and innovative oncolytic ...
6don MSNOpinion
US sunscreen faces biggest change in decades
The U.S. could soon see its biggest shift in sunscreen regulation in over 25 years as the FDA considers approving a new UV ...
The country wants to become a global leader in brain implants. Strong government support is expected to help accelerate that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results